Skip to main content
. Author manuscript; available in PMC: 2022 Mar 15.
Published in final edited form as: J Immunol. 2021 Feb 10;206(6):1284–1296. doi: 10.4049/jimmunol.2000772

Figure 2. Human liver express more of FcγRIIb than FcγRIIa.

Figure 2.

A. An ECL-developed Immunoblot (IB) using rabbit pAb showing FcγRIIb expression in human liver lysates and cell line lysates prepared as described in M&M. Numbers are MW markers in kDa. The IB are representative of data from 3 different human liver samples/biological replicates. B. An ECL-developed IB using rabbit pAb 260 showing FcγRIIa expression in human liver lysates and cell line lysates prepared as described in M&M. Numbers are MW markers in kDa. Numbers are molecular mass markers in kDa. The lower panels of A and B show loading control anti-β-actin. Arrows in top panels point the bands for FcγRIIb isoforms b1 and b2 (Panel A) and FcγRIIa (Panel B).